Bradykinin receptor antagonist

This page covers all Bradykinin receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting B2 receptor.

Targets

B2 receptor

Phase 2 pipeline (1)

• Deucrictibant high dose · Pharvaris Netherlands B.V. · Cardiovascular
  Deucrictibant is a bradykinin receptor 2 antagonist.

Patent intelligence

• bradykinin receptor antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates